Skip to search formSkip to main contentSkip to account menu

Adenocarcinoma

Known as: Adenoma, Malignant, Malignant Adenoma, Adenocarcinomas 
A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth… 
National Institutes of Health

Related topics

Related topics

50 relations

Narrower (11)

Adenocarcinoid tumorAdenocarcinoma Of EsophagusAdenocarcinoma in SituAdenocarcinoma in Tubulovillous Adenoma
Adenocarcinoma, Basal CellBasophilic AdenocarcinomaBlood supply aspectsBloom Syndrome

Broader (2)

CarcinomaNeoplasms

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Food, Nutrition, Physical Activity, and the Prevention of Cancer : a Global Perspective : 食物、栄養、身体活動とがんの予防 : 世界的展望(前篇)
physical activity and cancer fact sheet national cancer on this page what is physical activity what is known about the… 
Highly Cited
2011
Highly Cited
2011
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase…
Highly Cited
2011
Highly Cited
2011
Integrated Genomic Analyses of Ovarian Carcinoma
A catalogue of molecular aberrations that cause ovarian cancer is critical for developing and deploying therapies that will… 
Highly Cited
2011
Highly Cited
2011
Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium.
BACKGROUND & AIMS We previously established long-term culture conditions under which single crypts or stem cells derived from… 
Highly Cited
2009
Highly Cited
2009
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
BACKGROUND Previous, uncontrolled studies have suggested that first-line treatment with gefitinib would be efficacious in… 
Highly Cited
2006
Highly Cited
2006
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.
Highly Cited
2005
Highly Cited
2005
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
Background Lung adenocarcinomas from patients who respond to the tyrosine kinase inhibitors gefitinib (Iressa) or erlotinib… 
Highly Cited
2005
Highly Cited
2005
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa…
Highly Cited
2003
Highly Cited
2003
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.
Review
1989
Review
1989
ras oncogenes in human cancer: a review.
  • J. Bos
  • Cancer research
  • 1989
  • Corpus ID: 29749617
Mutations in codon 12, 13, or 61 of one of the three ras genes, H-ras, K-ras, and N-ras, convert these genes into active… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License